NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

抗菌的全球市場:各作物,各類型,各應用領域的市場調查,預測(∼2025年),COVID-19的累積性的影響

Antibacterial Market Research Report by Crop, by Type, by Application, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 1001068
出版日期 內容資訊 英文 197 Pages
商品交期: 最快1-2個工作天內
價格
抗菌的全球市場:各作物,各類型,各應用領域的市場調查,預測(∼2025年),COVID-19的累積性的影響 Antibacterial Market Research Report by Crop, by Type, by Application, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 197 Pages
簡介

全球抗菌的市場規模預測將從2020年的239億1,267萬美元,增長到2025年的349億2,165萬美元。

COVID-19是前所未有的全球性公共衛生突發事件,已影響到每個行業。這種長期影響預計將在預測期內影響行業增長。我們正在進行的研究正在擴大我們的研究範圍,以確保我們窮究潛在的COVID-19問題和未來路徑。該報告考慮了消費者行為和需求的變化,購買方式,供應鏈的重新改道,當前市場趨勢以及政府的重要介入等因素,提供有關COVID-19的洞察。

這份報告提供抗菌的世界市場調查,提供市場概要,市場成長要素及阻礙因素分析,市場機會,COVID-19的影響,作物·種類·應用·各地區的市場規模的變化與預測,競爭情形,主要企業的簡介等系統性資訊。

目錄

第1章 序文

  • 調查的目的
  • 市場區隔和涵蓋範圍
  • 調查涵蓋年份
  • 貨幣和價格
  • 語言
  • 限制事項
  • 利害關係者

第2章 調查手法

  • 調查流程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:調查設備
    • 收集:資料來源
    • 分析:資料的解釋
    • 制定:資料檢驗
    • 公開:調查報告
    • 重複:報告的更新
  • 調查的實行
    • 開始:調查流程
    • 計劃:調查計劃的作成
    • 實行:調查的實施
    • 檢驗:發現與分析
    • 出版物:調查報告
  • 調查成果

第3章 摘要整理

  • 市場預測
  • 作物預測
  • 應用預測
  • 種類預測
  • 地區預測
  • 其他競爭公司預測

第4章 市場概要

  • COVID-19累積的影響

第5章 市場洞察

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題
  • 波特的五力分析
    • 新加入廠商業者的威脅
    • 替代品的威脅
    • 客戶談判力
    • 供給企業談判力
    • 產業的競爭

第6章 各作物

  • 麥片穀類和穀物
  • 水果和蔬菜
  • 油籽和豆類

第7章 各類型

  • 醯胺抗菌
  • 抗生素抗菌
  • 銅基抗菌
  • 二硫代氨基甲酸抗菌

第8章 各應用領域

  • 葉面噴霧
  • 土壤處理

第9章 南北美洲

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太地區

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第11章 歐洲,中東·非洲

  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國
  • 英國

第12章 競爭情形

  • FPNV定位矩陣
    • 象限
    • 事業策略
    • 產品的滿意度
  • 市場排行榜分析
  • 市場佔有率分析
  • 其他競爭公司的SWOT分析
  • 競爭模式
    • 合併和收購
    • 協定,合作,及夥伴關係
    • 新產品的銷售與強化
    • 投資與資金籌措
    • 獎,獎勵,擴大

第13章 企業的實用性簡介

  • Allecra Therapeutics GmbH
  • Allergan PLC
  • AstraZeneca PLC
  • Bayer AG
  • Boston Pharmaceuticals Inc.
  • Bristol-Myers Squibb Company
  • Civica Rx
  • Cumberland Pharmaceuticals, Inc.
  • Debiopharm Group
  • Eli Lilly and Company
  • Entasis Therapeutics Hldg
  • Forest Laboratories, Inc.
  • GlaxoSmithKline plc
  • Iterum Therapeutics plc
  • Johnson & Johnson
  • Kyorin Pharmaceutical Co., Ltd.
  • Locus Biosciences Inc.
  • Melinta Therapeutics
  • Merck & Co., Inc.
  • Micurx Pharmaceutical Inc.
  • Mylan N.V.
  • Nabriva Therapeutics plc
  • NacuGen Therapeutics Inc.
  • Novartis AG
  • Pfizer Inc
  • R-Pharm Group
  • Sanofi S A
  • Shionogi Inc.
  • Sichuan Pharmaceutical Co., Ltd.
  • Spero Therapeutics
  • TenNor Therapeutics
  • Teva Pharmaceutical Industries Ltd.
  • Theravance Biopharma, Inc.
  • VenatoRx Pharmaceuticals, Inc.
  • Wockhardt Ltd.

第14章 附錄

  • 討論指南
  • 許可證和價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-43539E5D2F83

The Global Antibacterial Market size was estimated at USD 23.91 Billion in 2020 and expected to reach USD 25.91 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 8.70% to reach USD 39.46 Billion by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Antibacterial to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Crop, the Antibacterial Market was studied across Cereals & Grains, Fruits & Vegetables, and Oilseeds & Pulses.

Based on Type, the Antibacterial Market was studied across Amide Antibacterial, Antibiotic Antibacterial, Copper-Based Antibacterial, and Dithiocarbamate Antibacterial.

Based on Application, the Antibacterial Market was studied across Foliar Spray and Soil Treatment.

Based on Geography, the Antibacterial Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Antibacterial Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Antibacterial Market, including Allecra Therapeutics GmbH, Allergan PLC, AstraZeneca PLC, Bayer AG, Boston Pharmaceuticals Inc., Bristol-Myers Squibb Company, Civica Rx, Cumberland Pharmaceuticals, Inc., Debiopharm Group, Eli Lilly and Company, Entasis Therapeutics Hldg, Forest Laboratories, Inc., GlaxoSmithKline plc, Iterum Therapeutics plc, Johnson & Johnson, Kyorin Pharmaceutical Co., Ltd., Locus Biosciences Inc., Melinta Therapeutics, Merck & Co., Inc., Micurx Pharmaceutical Inc., Mylan N.V., Nabriva Therapeutics plc, NacuGen Therapeutics Inc., Novartis AG, Pfizer Inc, R-Pharm Group, Sanofi S A, Shionogi Inc., Sichuan Pharmaceutical Co., Ltd., Spero Therapeutics, TenNor Therapeutics, Teva Pharmaceutical Industries Ltd., Theravance Biopharma, Inc., VenatoRx Pharmaceuticals, Inc., and Wockhardt Ltd..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Antibacterial Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Antibacterial Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Antibacterial Market?
  • 4. What is the competitive strategic window for opportunities in the Global Antibacterial Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Antibacterial Market?
  • 6. What is the market share of the leading vendors in the Global Antibacterial Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Antibacterial Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Crop Outlook
  • 3.4. Application Outlook
  • 3.5. Type Outlook
  • 3.6. Geography Outlook
  • 3.7. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of infectious diseases
      • 5.1.1.2. Increasing level of antibiotic resistance infections
      • 5.1.1.3. Incidences of bacterial vaginosis and associated risk factors in pregnant women
    • 5.1.2. Restraints
      • 5.1.2.1. Side effects of antibacterial drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Developments to tackle the antibacterial resistance
      • 5.1.3.2. Rising approval and introduction of new antibacterial drugs
    • 5.1.4. Challenges
      • 5.1.4.1. Economic, social, and regulatory challenges during antibacterial development
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Antibacterial Market, by Crop

  • 6.1. Introduction
  • 6.2. Cereals & Grains
  • 6.3. Fruits & Vegetables
  • 6.4. Oilseeds & Pulses

7. Antibacterial Market, by Type

  • 7.1. Introduction
  • 7.2. Amide Antibacterial
  • 7.3. Antibiotic Antibacterial
  • 7.4. Copper-Based Antibacterial
  • 7.5. Dithiocarbamate Antibacterial

8. Antibacterial Market, by Application

  • 8.1. Introduction
  • 8.2. Foliar Spray
  • 8.3. Soil Treatment

9. Americas Antibacterial Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States
    • 9.6.1. California
    • 9.6.2. Florida
    • 9.6.3. Illinois
    • 9.6.4. New York
    • 9.6.5. Ohio
    • 9.6.6. Pennsylvania
    • 9.6.7. Texas

10. Asia-Pacific Antibacterial Market

  • 10.1. Introduction
  • 10.2. China
  • 10.3. India
  • 10.4. Indonesia
  • 10.5. Japan
  • 10.6. Malaysia
  • 10.7. Philippines
  • 10.8. South Korea
  • 10.9. Thailand

11. Europe, Middle East & Africa Antibacterial Market

  • 11.1. Introduction
  • 11.2. France
  • 11.3. Germany
  • 11.4. Italy
  • 11.5. Netherlands
  • 11.6. Qatar
  • 11.7. Russia
  • 11.8. Saudi Arabia
  • 11.9. South Africa
  • 11.10. Spain
  • 11.11. United Arab Emirates
  • 11.12. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
    • 12.1.1. Quadrants
    • 12.1.2. Business Strategy
    • 12.1.3. Product Satisfaction
  • 12.2. Market Ranking Analysis
  • 12.3. Market Share Analysis, By Quadrant
  • 12.4. Market Share Analysis, By Company
  • 12.5. Competitive Scenario
    • 12.5.1. Merger & Acquisition
    • 12.5.2. Agreement, Collaboration, & Partnership
    • 12.5.3. New Product Launch & Enhancement
    • 12.5.4. Investment & Funding
    • 12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles

  • 13.1. Allecra Therapeutics GmbH
  • 13.2. Allergan PLC
  • 13.3. AstraZeneca PLC
  • 13.4. Bayer AG
  • 13.5. Boston Pharmaceuticals Inc.
  • 13.6. Bristol-Myers Squibb Company
  • 13.7. Civica Rx
  • 13.8. Cumberland Pharmaceuticals, Inc.
  • 13.9. Debiopharm Group
  • 13.10. Eli Lilly and Company
  • 13.11. Entasis Therapeutics Hldg
  • 13.12. Forest Laboratories, Inc.
  • 13.13. GlaxoSmithKline plc
  • 13.14. Iterum Therapeutics plc
  • 13.15. Johnson & Johnson
  • 13.16. Kyorin Pharmaceutical Co., Ltd.
  • 13.17. Locus Biosciences Inc.
  • 13.18. Melinta Therapeutics
  • 13.19. Merck & Co., Inc.
  • 13.20. Micurx Pharmaceutical Inc.
  • 13.21. Mylan N.V.
  • 13.22. Nabriva Therapeutics plc
  • 13.23. NacuGen Therapeutics Inc.
  • 13.24. Novartis AG
  • 13.25. Pfizer Inc
  • 13.26. R-Pharm Group
  • 13.27. Sanofi S A
  • 13.28. Shionogi Inc.
  • 13.29. Sichuan Pharmaceutical Co., Ltd.
  • 13.30. Spero Therapeutics
  • 13.31. TenNor Therapeutics
  • 13.32. Teva Pharmaceutical Industries Ltd.
  • 13.33. Theravance Biopharma, Inc.
  • 13.34. VenatoRx Pharmaceuticals, Inc.
  • 13.35. Wockhardt Ltd.

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing
  • 14.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANTIBACTERIAL MARKET SIZE, 2020 VS 2026 (USD BILLION)
  • FIGURE 2. GLOBAL ANTIBACTERIAL MARKET SIZE, BY CROP, 2020 (USD BILLION)
  • FIGURE 3. GLOBAL ANTIBACTERIAL MARKET SIZE, BY APPLICATION, 2020 (USD BILLION)
  • FIGURE 4. GLOBAL ANTIBACTERIAL MARKET SIZE, BY TYPE, 2020 (USD BILLION)
  • FIGURE 5. GLOBAL ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2020 (USD BILLION)
  • FIGURE 6. GLOBAL ANTIBACTERIAL MARKET: MARKET DYNAMICS
  • FIGURE 7. GLOBAL ANTIBACTERIAL MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 8. GLOBAL ANTIBACTERIAL MARKET SIZE, BY CROP, 2020 VS 2026 (%)
  • FIGURE 9. GLOBAL ANTIBACTERIAL MARKET SIZE, BY CROP, 2020 VS 2026 (USD BILLION)
  • FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTIBACTERIAL MARKET SIZE, BY CROP, 2026
  • FIGURE 11. GLOBAL ANTIBACTERIAL MARKET SIZE, BY CEREALS & GRAINS, 2018-2026 (USD BILLION)
  • FIGURE 12. GLOBAL ANTIBACTERIAL MARKET SIZE, BY CEREALS & GRAINS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 13. GLOBAL ANTIBACTERIAL MARKET SIZE, BY FRUITS & VEGETABLES, 2018-2026 (USD BILLION)
  • FIGURE 14. GLOBAL ANTIBACTERIAL MARKET SIZE, BY FRUITS & VEGETABLES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 15. GLOBAL ANTIBACTERIAL MARKET SIZE, BY OILSEEDS & PULSES, 2018-2026 (USD BILLION)
  • FIGURE 16. GLOBAL ANTIBACTERIAL MARKET SIZE, BY OILSEEDS & PULSES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 17. GLOBAL ANTIBACTERIAL MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
  • FIGURE 18. GLOBAL ANTIBACTERIAL MARKET SIZE, BY TYPE, 2020 VS 2026 (USD BILLION)
  • FIGURE 19. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTIBACTERIAL MARKET SIZE, BY TYPE, 2026
  • FIGURE 20. GLOBAL ANTIBACTERIAL MARKET SIZE, BY AMIDE ANTIBACTERIAL, 2018-2026 (USD BILLION)
  • FIGURE 21. GLOBAL ANTIBACTERIAL MARKET SIZE, BY AMIDE ANTIBACTERIAL, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 22. GLOBAL ANTIBACTERIAL MARKET SIZE, BY ANTIBIOTIC ANTIBACTERIAL, 2018-2026 (USD BILLION)
  • FIGURE 23. GLOBAL ANTIBACTERIAL MARKET SIZE, BY ANTIBIOTIC ANTIBACTERIAL, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 24. GLOBAL ANTIBACTERIAL MARKET SIZE, BY COPPER-BASED ANTIBACTERIAL, 2018-2026 (USD BILLION)
  • FIGURE 25. GLOBAL ANTIBACTERIAL MARKET SIZE, BY COPPER-BASED ANTIBACTERIAL, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 26. GLOBAL ANTIBACTERIAL MARKET SIZE, BY DITHIOCARBAMATE ANTIBACTERIAL, 2018-2026 (USD BILLION)
  • FIGURE 27. GLOBAL ANTIBACTERIAL MARKET SIZE, BY DITHIOCARBAMATE ANTIBACTERIAL, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 28. GLOBAL ANTIBACTERIAL MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
  • FIGURE 29. GLOBAL ANTIBACTERIAL MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD BILLION)
  • FIGURE 30. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTIBACTERIAL MARKET SIZE, BY APPLICATION, 2026
  • FIGURE 31. GLOBAL ANTIBACTERIAL MARKET SIZE, BY FOLIAR SPRAY, 2018-2026 (USD BILLION)
  • FIGURE 32. GLOBAL ANTIBACTERIAL MARKET SIZE, BY FOLIAR SPRAY, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 33. GLOBAL ANTIBACTERIAL MARKET SIZE, BY SOIL TREATMENT, 2018-2026 (USD BILLION)
  • FIGURE 34. GLOBAL ANTIBACTERIAL MARKET SIZE, BY SOIL TREATMENT, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 35. AMERICAS ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 36. AMERICAS ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 38. ARGENTINA ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 39. BRAZIL ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 40. CANADA ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 41. MEXICO ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 42. UNITED STATES ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 43. CALIFORNIA ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 44. FLORIDA ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 45. ILLINOIS ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 46. NEW YORK ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 47. OHIO ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 48. PENNSYLVANIA ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 49. TEXAS ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 50. ASIA-PACIFIC ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 51. ASIA-PACIFIC ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 52. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 53. CHINA ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 54. INDIA ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 55. INDONESIA ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 56. JAPAN ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 57. MALAYSIA ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 58. PHILIPPINES ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 59. SOUTH KOREA ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 60. THAILAND ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 61. EUROPE, MIDDLE EAST & AFRICA ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 62. EUROPE, MIDDLE EAST & AFRICA ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 63. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 64. FRANCE ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 65. GERMANY ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 66. ITALY ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 67. NETHERLANDS ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 68. QATAR ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 69. RUSSIA ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 70. SAUDI ARABIA ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 71. SOUTH AFRICA ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 72. SPAIN ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 73. UNITED ARAB EMIRATES ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 74. UNITED KINGDOM ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 75. GLOBAL ANTIBACTERIAL MARKET: FPNV POSITIONING MATRIX
  • FIGURE 76. GLOBAL ANTIBACTERIAL MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 77. GLOBAL ANTIBACTERIAL MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 78. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ANTIBACTERIAL MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL ANTIBACTERIAL MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL ANTIBACTERIAL MARKET SIZE, BY CROP, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 4. GLOBAL ANTIBACTERIAL MARKET SIZE, BY CEREALS & GRAINS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 5. GLOBAL ANTIBACTERIAL MARKET SIZE, BY FRUITS & VEGETABLES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 6. GLOBAL ANTIBACTERIAL MARKET SIZE, BY OILSEEDS & PULSES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 7. GLOBAL ANTIBACTERIAL MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 8. GLOBAL ANTIBACTERIAL MARKET SIZE, BY AMIDE ANTIBACTERIAL, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 9. GLOBAL ANTIBACTERIAL MARKET SIZE, BY ANTIBIOTIC ANTIBACTERIAL, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 10. GLOBAL ANTIBACTERIAL MARKET SIZE, BY COPPER-BASED ANTIBACTERIAL, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 11. GLOBAL ANTIBACTERIAL MARKET SIZE, BY DITHIOCARBAMATE ANTIBACTERIAL, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 12. GLOBAL ANTIBACTERIAL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 13. GLOBAL ANTIBACTERIAL MARKET SIZE, BY FOLIAR SPRAY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 14. GLOBAL ANTIBACTERIAL MARKET SIZE, BY SOIL TREATMENT, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 15. AMERICAS ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 16. AMERICAS ANTIBACTERIAL MARKET SIZE, BY CROP, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 17. AMERICAS ANTIBACTERIAL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 18. AMERICAS ANTIBACTERIAL MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 19. ARGENTINA ANTIBACTERIAL MARKET SIZE, BY CROP, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 20. ARGENTINA ANTIBACTERIAL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 21. ARGENTINA ANTIBACTERIAL MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 22. BRAZIL ANTIBACTERIAL MARKET SIZE, BY CROP, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 23. BRAZIL ANTIBACTERIAL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 24. BRAZIL ANTIBACTERIAL MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 25. CANADA ANTIBACTERIAL MARKET SIZE, BY CROP, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 26. CANADA ANTIBACTERIAL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 27. CANADA ANTIBACTERIAL MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 28. MEXICO ANTIBACTERIAL MARKET SIZE, BY CROP, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 29. MEXICO ANTIBACTERIAL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 30. MEXICO ANTIBACTERIAL MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 31. UNITED STATES ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 32. UNITED STATES ANTIBACTERIAL MARKET SIZE, BY CROP, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 33. UNITED STATES ANTIBACTERIAL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 34. UNITED STATES ANTIBACTERIAL MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 35. CALIFORNIA ANTIBACTERIAL MARKET SIZE, BY CROP, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 36. CALIFORNIA ANTIBACTERIAL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 37. CALIFORNIA ANTIBACTERIAL MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 38. FLORIDA ANTIBACTERIAL MARKET SIZE, BY CROP, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 39. FLORIDA ANTIBACTERIAL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 40. FLORIDA ANTIBACTERIAL MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 41. ILLINOIS ANTIBACTERIAL MARKET SIZE, BY CROP, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 42. ILLINOIS ANTIBACTERIAL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 43. ILLINOIS ANTIBACTERIAL MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 44. NEW YORK ANTIBACTERIAL MARKET SIZE, BY CROP, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 45. NEW YORK ANTIBACTERIAL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 46. NEW YORK ANTIBACTERIAL MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 47. OHIO ANTIBACTERIAL MARKET SIZE, BY CROP, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 48. OHIO ANTIBACTERIAL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 49. OHIO ANTIBACTERIAL MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 50. PENNSYLVANIA ANTIBACTERIAL MARKET SIZE, BY CROP, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 51. PENNSYLVANIA ANTIBACTERIAL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 52. PENNSYLVANIA ANTIBACTERIAL MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 53. TEXAS ANTIBACTERIAL MARKET SIZE, BY CROP, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 54. TEXAS ANTIBACTERIAL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 55. TEXAS ANTIBACTERIAL MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 56. ASIA-PACIFIC ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 57. ASIA-PACIFIC ANTIBACTERIAL MARKET SIZE, BY CROP, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 58. ASIA-PACIFIC ANTIBACTERIAL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 59. ASIA-PACIFIC ANTIBACTERIAL MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 60. CHINA ANTIBACTERIAL MARKET SIZE, BY CROP, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 61. CHINA ANTIBACTERIAL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 62. CHINA ANTIBACTERIAL MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 63. INDIA ANTIBACTERIAL MARKET SIZE, BY CROP, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 64. INDIA ANTIBACTERIAL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 65. INDIA ANTIBACTERIAL MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 66. INDONESIA ANTIBACTERIAL MARKET SIZE, BY CROP, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 67. INDONESIA ANTIBACTERIAL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 68. INDONESIA ANTIBACTERIAL MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 69. JAPAN ANTIBACTERIAL MARKET SIZE, BY CROP, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 70. JAPAN ANTIBACTERIAL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 71. JAPAN ANTIBACTERIAL MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 72. MALAYSIA ANTIBACTERIAL MARKET SIZE, BY CROP, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 73. MALAYSIA ANTIBACTERIAL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 74. MALAYSIA ANTIBACTERIAL MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 75. PHILIPPINES ANTIBACTERIAL MARKET SIZE, BY CROP, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 76. PHILIPPINES ANTIBACTERIAL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 77. PHILIPPINES ANTIBACTERIAL MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 78. SOUTH KOREA ANTIBACTERIAL MARKET SIZE, BY CROP, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 79. SOUTH KOREA ANTIBACTERIAL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 80. SOUTH KOREA ANTIBACTERIAL MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 81. THAILAND ANTIBACTERIAL MARKET SIZE, BY CROP, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 82. THAILAND ANTIBACTERIAL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 83. THAILAND ANTIBACTERIAL MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA ANTIBACTERIAL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA ANTIBACTERIAL MARKET SIZE, BY CROP, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA ANTIBACTERIAL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA ANTIBACTERIAL MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 88. FRANCE ANTIBACTERIAL MARKET SIZE, BY CROP, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 89. FRANCE ANTIBACTERIAL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 90. FRANCE ANTIBACTERIAL MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 91. GERMANY ANTIBACTERIAL MARKET SIZE, BY CROP, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 92. GERMANY ANTIBACTERIAL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 93. GERMANY ANTIBACTERIAL MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 94. ITALY ANTIBACTERIAL MARKET SIZE, BY CROP, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 95. ITALY ANTIBACTERIAL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 96. ITALY ANTIBACTERIAL MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 97. NETHERLANDS ANTIBACTERIAL MARKET SIZE, BY CROP, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 98. NETHERLANDS ANTIBACTERIAL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 99. NETHERLANDS ANTIBACTERIAL MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 100. QATAR ANTIBACTERIAL MARKET SIZE, BY CROP, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 101. QATAR ANTIBACTERIAL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 102. QATAR ANTIBACTERIAL MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 103. RUSSIA ANTIBACTERIAL MARKET SIZE, BY CROP, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 104. RUSSIA ANTIBACTERIAL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 105. RUSSIA ANTIBACTERIAL MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 106. SAUDI ARABIA ANTIBACTERIAL MARKET SIZE, BY CROP, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 107. SAUDI ARABIA ANTIBACTERIAL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 108. SAUDI ARABIA ANTIBACTERIAL MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 109. SOUTH AFRICA ANTIBACTERIAL MARKET SIZE, BY CROP, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 110. SOUTH AFRICA ANTIBACTERIAL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 111. SOUTH AFRICA ANTIBACTERIAL MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 112. SPAIN ANTIBACTERIAL MARKET SIZE, BY CROP, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 113. SPAIN ANTIBACTERIAL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 114. SPAIN ANTIBACTERIAL MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 115. UNITED ARAB EMIRATES ANTIBACTERIAL MARKET SIZE, BY CROP, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 116. UNITED ARAB EMIRATES ANTIBACTERIAL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 117. UNITED ARAB EMIRATES ANTIBACTERIAL MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 118. UNITED KINGDOM ANTIBACTERIAL MARKET SIZE, BY CROP, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 119. UNITED KINGDOM ANTIBACTERIAL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 120. UNITED KINGDOM ANTIBACTERIAL MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 121. GLOBAL ANTIBACTERIAL MARKET: SCORES
  • TABLE 122. GLOBAL ANTIBACTERIAL MARKET: BUSINESS STRATEGY
  • TABLE 123. GLOBAL ANTIBACTERIAL MARKET: PRODUCT SATISFACTION
  • TABLE 124. GLOBAL ANTIBACTERIAL MARKET: RANKING
  • TABLE 125. GLOBAL ANTIBACTERIAL MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 126. GLOBAL ANTIBACTERIAL MARKET: SHARE, BY COMPANY, 2020
  • TABLE 127. GLOBAL ANTIBACTERIAL MARKET: MERGER & ACQUISITION
  • TABLE 128. GLOBAL ANTIBACTERIAL MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 129. GLOBAL ANTIBACTERIAL MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 130. GLOBAL ANTIBACTERIAL MARKET: INVESTMENT & FUNDING
  • TABLE 131. GLOBAL ANTIBACTERIAL MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 132. GLOBAL ANTIBACTERIAL MARKET: LICENSE & PRICING
  • TABLE 133. GLOBAL ANTIBACTERIAL MARKET: CONTACT DETAILS